ArticleJournal of the American Academy of Dermatology2020
COVID-19 and immunomodulator/immunosuppressant use in dermatology.
Article in Journal of the American Academy of Dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effect of immunosuppressive drugs in immune-mediated inflammatory disease during the coronavirus pandemic.Dermatologic therapy · 2020Pooled it
- Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.Dermatologic therapy · 2020Pooled it
- Dermatology Publications on COVID-19 during the First Pandemic Year: Creativity or Opportunism?Life (Basel, Switzerland) · 2023Article
- Complexity of the Immune Response Elicited by Different COVID-19 Vaccines, in the Light of Natural Autoantibodies and Immunomodulatory Therapies.International journal of molecular sciences · 2023Article
- A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals.Frontiers in medicine · 2023Review
- [Translated article] Practical Guide to New Treatments for SARS-CoV-2 Infection in Dermatology Patients Being Treated With Common Immunomodulators.Actas dermo-sifiliograficas · 2023Article
- COVID-19 Pandemic Impact on Severe Alopecia Areata Patients.Skin appendage disorders · 2022Article
- The immunology and immunotherapy for COVID-19.Expert reviews in molecular medicine · 2021Review
- Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19.International journal of women's dermatology · 2021Review
- Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis.Health science reports · 2021Article
- COVID-19 infection risk in patients on immunosuppressive/immunomodulator therapy: A single center study.Dermatologic therapy · 2021Article
- Recommendations for Pediatric Dermatology Practice during COVID-19 Pandemic.Indian dermatology online journal · 2021Article
- Uric acid as a prognostic factor and critical marker of COVID-19.Scientific reports · 2021Observational
- Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.American journal of clinical dermatology · 2021Review
- Is systemic isotretinoin use a risk factor for coronavirus disease 2019 (COVID-19)?Journal of cosmetic dermatology · 2021Article
- The Effect of SARS-CoV-2 Virus Infection on the Course of Atopic Dermatitis in Patients.Medicina (Kaunas, Lithuania) · 2021Article
- Immunobiology and immunotherapy of COVID-19: A clinically updated overview.Journal of cellular physiology · 2021Review
- Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital.European journal of dermatology : EJD · 2021Article
- Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Acute pancreatic injuries: A complication of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with cytotoxic immunocell activation.Journal of the American Academy of Dermatology · 2021Article
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.